Linc AB (LINC.ST) Research

Linc AB operates as a private equity and venture capital firm, dedicating its investments to the pharmaceutical, life sciences, and med-tech sectors across early, mid, and late venture stages. The firm prioritizes investment opportunities within Nordic companies. Its typical investment amounts range from SEK 25 million to SEK 250 million, frequently beginning with a relatively smaller initial capital injection, with subsequent follow-up investments constituting the majority of its financial commitment. Linc AB's headquarters are located in Stockholm, Sweden.

Market snapshot

Symbol
LINC.ST
Price
$68.50
Day change
-1.86%
Market cap
$4.0B
P/E ratio
9.51x
52-week range
58.9-83.6
Sector
Financial Services
Industry
Asset Management

Peer companies

  • Catella AB (publ) (CAT-B.ST)
  • Enity Holding AB (ENITY.ST)
  • Idun Industrier AB (publ) (IDUN-B.ST)
  • Karnell Group AB ser. B (KARNEL-B.ST)
  • Investment AB Öresund (publ) (ORES.ST)
  • Svolder AB (publ) (SVOL-B.ST)
  • AB Traction (TRAC-B.ST)
  • VEF AB (Publ) (VEFAB.ST)

Open Linc AB (LINC.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.